Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

XIAMEN SPACEGEN CO.,LTD
Connect with this vendor - Learn about this product

Human Oncology Multi-Gene Mutations Detection Kit

Human Oncology Multi-Gene Mutations Detection Kit Human Oncology Multi-Gene Mutations Detection Kit Next Generation Sequencing CE-IVD Certificate no.:No.MDD-SZ-XW-160321 For scientific research use in China Gene Mutation and Tumor Apart from red blood cell, each one of human cells contains DNA, which is composed of 20,000 to 25,000 genes. The gene mutation is classified into random mutations and genetic mutations. Following the accumulation of increased harmful gene mutations, tumorigenesis would beignited by mutation of a key gene finally. Targeted drugs are able to target the pathologic molecules caused by specific gene mutations, which will improve efficacy of the drugs and reduce the side effects. Therefore,through genetic testing, we can understand the situation of gene mutations of patients, which is a key indicator todetermine whether they can benefit from targeted drug treatments or not.